CD274 and cancer: In short, we aim to propose strategies targeting PD-L1 expression and associated opportunities for cancer combination here and also hope more drugs and nanocomposites as well as antibodies would be achieved clinical translation to address the bottlenecks and maximize the advantages of immunotherapy.